Serenex Invited to Present at the BioCentury and Thomson Financial -- "Future Leaders in The Biotech Industry"

DURHAM, NC -- (MARKET WIRE) -- March 22, 2007 -- Serenex, Inc., an integrated oncology-focused drug discovery and development company, announced today that Dr. Richard Kent, chief executive officer, is scheduled to present at the Future Leaders in The Biotech Industry conference, hosted by BioCentury, taking place March 29th, 2007, at the Millennium Broadway Hotel in New York City.

Back to news